Search results
Results From The WOW.Com Content Network
Paroxetine, sold under the brand name Paxil among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. [7] It is used to treat major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, post-traumatic stress disorder, generalized anxiety disorder, and premenstrual dysphoric disorder. [7]
The Ho Chi Minh City University of Social Sciences and Humanities (HCMUSSH; Vietnamese: Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Thành phố Hồ Chí Minh), or VNU-HCM University of Social Sciences and Humanities, is one of the members of Vietnam National University, Ho Chi Minh City system (VNU-HCM).
Contents. Development and discovery of SSRI drugs. Selective serotonin reuptake inhibitors, or serotonin-specific re-uptake inhibitor (SSRIs), are a class of chemical compounds that have application as antidepressants and in the treatment of depression and other psychiatric disorders. SSRIs are therapeutically useful in the treatment of panic ...
Lunesta (eszopiclone) – a non-benzodiazepine hypnotic. Luvox (fluvoxamine) – an antidepressant of the SSRI class. Loxitane (loxapine) – an antipsychotic used in the treatment of mood disorders and schizophrenia. Lyrica (pregabalin) – treats nerve and muscle pain, including fibromyalgia. It can also treat seizures.
Vietnam National University, Hanoi (VNU; Vietnamese: Đại học Quốc gia Hà Nội, ĐHQGHN) is a public research university system in Hanoi, Vietnam. The university system has 10 member universities and faculties. VNU is one of two Vietnam's national universities, the other one being Vietnam National University, Ho Chi Minh City.
The second-generation antidepressants are a class of antidepressants characterized primarily by the era of their introduction, approximately coinciding with the 1970s and 1980s, rather than by their chemical structure or by their pharmacological effect. As a consequence, there is some controversy over which treatments actually belong in this class.
Study 329 was a clinical trial which was conducted in North America from 1994 to 1998 to study the efficacy of paroxetine, an SSRI anti-depressant, in treating 12- to 18-year-olds diagnosed with major depressive disorder. Led by Martin Keller, then professor of psychiatry at Brown University, and funded by the British pharmaceutical company ...
From Wikipedia, the free encyclopedia. Redirect page. Redirect to: Paroxetine; This page is a ...